EUCR

Eucrates Biomedical Acquisition Corp. Ordinary Shares

Delisted

EUCR was delisted on the 26th of April, 2023.

5 hedge funds and large institutions have $2.98M invested in Eucrates Biomedical Acquisition Corp. Ordinary Shares in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
-33
Holders Change %
-86.84%
% of All Funds
0.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
2
Closed
34
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Millennium Management
26
Millennium Management
New York
-$802K -80,000 Closed
CF
27
Cantor Fitzgerald
New York
-$741K -74,000 Closed
MC
28
Meteora Capital
Florida
-$562K -56,076 Closed
CIM
29
Cowen Investment Management
New York
-$501K -50,000 Closed
Goldman Sachs
30
Goldman Sachs
New York
-$307K -30,622 Closed
T. Rowe Price Associates
31
T. Rowe Price Associates
Maryland
-$225K -22,427 Closed
MSU
32
Mizuho Securities USA
New York
-$192K -19,136 Closed
RL
33
RPO LLC
Connecticut
-$191K -19,012 Closed
LCM
34
Landscape Capital Management
New Jersey
-$129K -12,888 Closed
Morgan Stanley
35
Morgan Stanley
New York
-$39K -3,900 Closed
WCMNY
36
Westchester Capital Management (New York)
New York
-$11K -1,100 Closed
EC
37
Elequin Capital
New York
-$5K -500 Closed
AI
38
Arena Investors
New York
-$1.81K -180 Closed